FindTrial
Sign In

Comparing Risperidone and Olanzapine: which is safer and more effective for schizophrenia treatment at a tertiary teaching hospital, Haldwani, Uttarakhand

Comparative study of efficacy and safety profile of Risperidone and olanzapine in patients of schizophrenia in tertiary care teaching hospital,haldwani - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/05/109933
Enrollment
90
Registered
2026-05-04
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F209- Schizophrenia, unspecified

Interventions

Intervention1: Oral Risperidone: Risperidone(2-3) mg twice a day titrated up to 8mg/day. Control Intervention1: Oral Olanzapine: Olanzapine (5-20) mg once a day titrated up to 20mg/day

Sponsors

MS Abinesh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient aged 18-60 years of age having schizophrenia presenting to opd /ipd will be enrolled.

Exclusion criteria

Exclusion criteria: Pregnant and lactating women. Patient not willing to participate in the study. Patient is known hypersensitivity to risperidone and olanzapine. Patients in the age group 60 years. Patients with any serious co morbid illness like Glaucoma, BPH, cancer, TB, HIV, AIDS and LEPROSY

Design outcomes

Primary

MeasureTime frame
To compare the efficacy of risperidone with olanzapine in patients with schizophrenia Timepoint: First day,1 week,6 week—

Secondary

MeasureTime frame
To observe the adverse drug reaction of risperidone & olanzapine in patients with schizophrenia during the course of the study. To study the socio demographic profile of the patient of the SchizophreniaTimepoint: Baseline,1st week,6th week—

Countries

India

Contacts

Public ContactBhavana Srivastava

Government Medical College, Haldwani

drsbhavana@gmail.com7895782824

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026